It is plausible that the therapeutic outcome of intervening with PD-1|PD-L1 signaling may differ when using other models of PKD such as germline Pkd2 or ciliopathy models, as well as inducible kidney-specific Pkd1 or Pkd2 knockout models. The gene discussed is PKD2; the disease is ciliopathy.